Key facts
- Develop Health’s last known valuation is $54.5M (Sep 2025).
- It has raised $17.6M across 1 recorded rounds; the latest was Early Stage VC ($17.6M) in Jun 2025.
- Notable investors include South Park Commons, Afore Capital, Wing Venture Capital, Agi House, Analog Ventures — 7 tracked in total.
- Develop Health has filed 1 Form D with the SEC, most recently Sep 2025 ($17.6M sold to 27 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 7 names
- ·Watchlist + deal alerts for Develop Health
Funding rounds
1 roundsAbout Develop Health
Developer of an AI-driven medication platform designed to streamline the prior authorization process in healthcare. The company's platform offers intelligent automation powered by AI to fill prior authorization forms efficiently, reducing administrative time and suggesting care plan modifications to optimize approval rates, enabling healthcare providers to handle prior authorizations more effectively and improve patient satisfaction while reducing administrative burden.
- Sector
- Healthcare
- HQ
- Menlo Park, CA, United States
- Founded
- 2022
- Employees
- 9
- Website
- develophealth.ai/
- Ownership
- Privately Held (backing)
Develop Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Develop Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Develop Health in its N-PORT filings yet. We sweep new filings monthly.